PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative ColitisGASTROENTEROLOGYIF25.12021-12-0129OA
THE BIOMARKER PROFILE OF PTG-200, AN ORAL PEPTIDE ANTAGONIST OF IL-23 RECEPTOR, TRACKS WITH EFFICACY IN A PRECLINICAL MODEL OF IBDGASTROENTEROLOGYIF25.12017-04-018PREAI
Discovery of Novel and Potent Orally Stable Peptide Antagonistsof the Human IL-23 Receptor and Their Pre-Clinical POC in Rat Colitis ModelsGASTROENTEROLOGYIF25.12016-04-010PREAI
Establishing the Human Equivalent Dose for Ptg-100, an Oral Peptide Antagonist of Integrin α4β7GASTROENTEROLOGYIF25.12016-04-010PREAI
Discovery of a Novel Class of Potent and Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 AntagonistsJOURNAL OF MEDICINAL CHEMISTRYIF6.82012-01-2422PREAI